Israeli medtech firm Nanox worth over $1.2b. with no revenue, FDA approval
Despite lacking approval or revenue, its share price has continued to soar.
An electronic board displaying market data is seen at the entrance of the Tel Aviv Stock Exchange, in Tel Aviv, Israel
